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CASE REPORT
MEDICAL LIABILITY
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ABSTRACT: A rare case of lethal idiopathic plasmacytic lymphadenopathy (IPL) with polyclonal hyperimmunoglobulinemia with chronic
renal failure is described. A 40-year-old woman who had suffered from upper airways disease was admitted to the Emergency Room with acute
renal failure and hypergammaglobulinemia. She developed pericardial effusion, a pruritic rash, splenomegaly and fell into a coma after 6 days.
Multiple myeloma, infection, collagenopathy, and coagulopathy were ruled out. Finally, a form of malignant hypergammapathy was suspected.
At autopsy, lymph nodes were infiltrated by polyclonal plasma cells and lymphocytes, with erythrophagocytosis features; immunohistochem-
istry confirmed the plasma cells (CD138+), with a prevalence of kappa-positive cells, B (CD20+) and T (CD3+) cells. Kidneys showed
advanced glomerulosclerosis containing similar infiltrates. The cause of death was IPL with polyclonal hypergammaglobulinemia and advanced
renal failure. Similar cases are unusual, and possible medical liability associated with failure to diagnose and treat idiopathic plasmacytic lym-
phadenopathy deserves discussion and further studies.
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Idiopathic plasmacytic lymphadenopathy (IPL) was first
described by Mori et al. in the early 1980s as a new disease
type, similar to the plasma cell type disorder, Castleman’s dis-
ease (CD). Both have multicentric lymphadenopathy, prominent
polyclonal hypergammaglobulinemia, an elevated erythrocyte
sedimentation rate, elevated serum interleukin-6 (IL6) concentra-
tions, bone marrow plasmacytosis, and abnormal laboratory data
such as anemia and positive autoantibodies. CD usually has an
aggressive and fatal outcome associated with infectious compli-
cations or malignant tumors (1–4). IPL has a significantly better
5-year survival rate than CD but can be asymptomatic for a long
time before exhibiting a rapidly fatal course due to an unex-
pected acute attack (4). This pathology is rarely recognized clini-
cally and may be first diagnosed after the patient’s death, even
after admission to hospital, where prompt, successful treatment
is expected. In this report, we describe the case of a patient
admitted to hospital for acute renal failure and hypergammaglob-
ulinemia, thought to be related to multiple myeloma. Several
alternative diagnostic hypotheses were made, but no relief of the
symptoms occurred despite the administration of therapy. The
patient developed deep coma and died a few days later without
a diagnosis; medical liability was suspected.
Case History
A 40-year-old woman was admitted to the Emergency Room
of a Southern Italy hospital with acute renal failure and hyper-
gammaglobulinemia. She had a medical history of frequent oti-
tis, pharyngitis, and poorly defined rheumatic disease. In the last
month, she had been taking oral antibiotics, but she developed
peripheral edema with initial renal failure, shown by biochemical
tests, with high proteinuria, as well as polyclonal hypergamma-
globulinemia at serum protein electrophoresis (Fig. 1). She was
moved to the Hematology Unit with a diagnosis of multiple
myeloma, but after 5 days she developed, in sequence, back
pain, pericardial effusion, and a pruritic rash of the face and
trunk with eyelid swelling, treated by analgesics and antihis-
tamines. An enlargement of the spleen was detected, with non-
palpable liver and lymph nodes. Her blood pressure was high
despite therapy. The respiratory function was normal. The next
day she became hypothermic (after initial hyperthermia), disori-
ented, agitated, and confused with eye deviation; a brain hemor-
rhage was suspected, and the patient was moved to the Intensive
Care Unit, where she was intubated. Thoracic computed
tomography showed a posterior pleural effusion with partially
collapsed lungs and interstitial thickening. On day 6 from admis-
sion, the patient became unconscious and then comatose; a lum-
bar puncture showed proteinorachia at 3035 mg/L, glycorrhachia
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at 19 mg/dL, and numerous erythrocytes and mononuclear cells
in the sediment. She underwent magnetic resonance imaging
(MRI) with angio-MRI, which was normal except for nonspeci-
fic sinusitis. In the next few days, the Glasgow Coma Scale
score decreased to 3. A full-body CT scan with contrast agent
showed massive brain swelling and sinusitis, multiple subcen-
timeter axillary, supra clavicular and mediastinal lymph nodes,
massive adipose tissue swelling of the thorax and abdomen, peri-
cardial effusion, 17 mm thick, and left pleural effusion with a
collapsed lung and interstitial thickening, splenomegaly, and
signs of acute kidney failure.
At admission, the biochemical and serological tests had
revealed renal dysfunction and an electrolytes imbalance. The
diagnosis of multiple myeloma was ruled out because of the
polyclonal pattern and the absence of bone lesions. Bone mar-
row survey showed 75% cellularity and polyclonal plasmacyto-
sis. The first measurement of serum immunoglobulin (Ig) levels
revealed the following values: IgG, 5933 mg/dL; IgA, 648 mg/
dL; IgM, 946 mg/dL; kappa and lambda Ig light chains,
1283 mg/dL and 829 mg/dL, respectively, with no monoclonal
values in urine, confirming the polyclonal pattern. The serologi-
cal tests revealed anemia, low levels of leukocytes and lympho-
cytes with a normal platelet count. On the following days, the
tests showed an increasing lymphocytopenia, thrombocytopenia,
and leukocytosis with normal clotting parameters. Coagulative
(such as thrombotic thrombocytopenic purpura) and collagen dis-
orders were suspected, or else an infectious disease in view of
the elevated levels of C-reactive protein, erythrocyte sedimenta-
tion rate, and procalcitonin, but these hypotheses were then ruled
out, and the search for infectious agents was negative. Antibiotic
and corticosteroid therapy was administered, but no relief of
symptoms obtained. Of note, a further serum protein elec-
trophoresis revealed a decrease of the total serum protein and
hypergammaglobulinemia levels. While the additional suspicion
of a hypergammaglobulinemia, symptomatic of a proliferative
hematological disorder, had been raised, a multi-organ failure
syndrome developed and the patient died 9 days after admission.
A forensic autopsy was requested to shed light on the cause of
death and to exclude medical malpractice.
Autopsy Findings
The skin was rash-free. The brain showed massive swelling.
The lungs were edematous with diffuse pleural adhesions. The
heart was heavy (500 g) with concentric hypertrophy of the left
ventricle. The spleen and liver were both enlarged (the spleen
350 g; the liver 1590 g); lymph nodes throughout the body were
slightly enlarged. Both kidneys were pale and cystic, with no
preservation of corticomedullary differentiation. Diffuse visceral
congestion was also observed.
Toxicological analyses were unremarkable.
Microscopic Findings
Samples of the main organs were taken at autopsy, fixed in
10% formalin, and routinely processed by hematoxylin–eosin
(H-E) staining and for immunohistochemistry. Lymph nodes
showed diffuse infiltrates of plasma cells and lymphocytes, with
erythrophagocytosis features (Fig. 2). Immunohistochemical
staining confirmed the plasma cells (CD138+), with a prevalence
of kappa-positive cells, B (CD20+) and T (CD3+) cells
(Fig. 3A–D); expression of anti-apoptotic Bcl-2 protein and pro-
liferation-related Ki-67 antigen was normal. The kidneys showed
advanced glomerulosclerosis containing similar infiltrates and
tubular protein cylinders, with massive sclero-hyalinosis (Fig. 4).
Samples from the tongue and kidneys were negative at Congo
red staining. An antemortem peripheral smear, obtained 2 days
before death, showed rouleaux formations of red cells, moderate
anisopoikilocytosis, and rare schistocytes.
These results confirmed that the cause of death was multiple
organ failure, due to IPL with polyclonal hypergammaglobuline-
mia and advanced kidney failure.
Discussion
Idiopathic plasmacytic lymphadenopathy features clonal
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FIG. 1––Laboratory findings on admission.
FIG. 2––Microscopic examination of lymph nodes: diffuse infiltrates of
plasma cells and lymphocytes with erythrophagocytosis features (H&E stain
95 magnification).
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immunoglobulin and/or their chains, which affect the entire
body. The clinical features are polymorphic because of the
involvement of several organs (the skin, and pulmonary, diges-
tive, and renal systems) (4–6). The treatment of IPL has not yet
been established, but some authors have indicated the efficacy of
corticosteroid treatment, anticancer chemotherapy, and mono-
clonal antibodies (7,8).
Even if ILP has been reported in literature, it is rarely recog-
nized clinically and may be first diagnosed after the patient’s death
(9), disclosed by the forensic pathologist as medical examiner.
Mori et al. developed the following diagnostic criteria for
IPL: (i) polyclonal hyperimmunoglobulinemia without M protein
(Ig G exceeding 4500 mg/dL); (ii) systemic lymphadenopathy
(>1.8 cm in diameter) with high plasmacytic infiltration but
without deterioration of the basic structure; (iii) the exclusion of
other diseases including infection, collagen, and autoimmune dis-
eases, hepatitis and liver cirrhosis (7,10,11). The case described
here fulfilled these criteria, and the diagnosis of IPL was formu-
lated. Polyclonal plasmacytosis in bone marrow was also
observed, a feature that frequently occurs in patients with IPL
(1). Nevertheless, a differential diagnosis with other conditions
in which bone marrow plasmacytosis may occur, for example,
chronic inflammation, infectious, and autoimmune diseases,
hypersensitivity, may be difficult (12).
Unfortunately, in the present case, the rapid worsening of the
patient’s condition did not allow the physicians to make a cor-
rect diagnosis, despite therapy. The case was particularly notable
for the renal complications resulting from glomerulosclerosis and
interstitial infiltration. Cases of fatal polyclonal systemic prolifer-
ations with renal failure are rare and have mostly been described
by Japanese authors (3,8,13–15). The exact etiologic mecha-
nisms of renal damage in IPL are unknown. It is thought that an
overproduction of IL6 may induce proliferation of mesangial
cells and interstitial infiltration of plasma cells into the renal
interstitium, and these processes can be increased by paracrine
or autocrine IL-6 production by mesangial cells and infiltrating
plasma cells (3).
FIG. 3––Immunohistochemical staining confirmed (A) the plasma cells with (B) a prevalence of kappa-positive cells, (C) cells type B, and (D) cells type T
(CD138 – Kappa Chain – CD20+ – CD3+ Immunohistochemistry 95 and 920 magnification).
FIG. 4––Microscopic examination of the kidneys showed advanced
glomerulosclerosis containing similar infiltrates and tubular protein cylin-
ders, with massive sclero-hyalinosis (H&E stain 95 magnification).
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The occurrence of renal dysfunction should be considered,
progressively worsening the patient’s clinical course in IPL. In
the present case, the renal damage resulted from glomeruloscle-
rosis due to the infiltration of plasma cells into the interstitium,
but the renal failure was refractory to corticosteroid therapy; this
is the main therapy because it can contrast the overproduction of
IL-6, inhibiting the release of pro-inflammatory cytokines (such
as IL-6) by macrophages and T- and B-lymphocytes. Indeed, the
therapy was actually effective in our patient, in terms of reduc-
ing the hypergammaglobulinemia, but no clinical improvement
was observed.
In retrospect, the patient’s initial clinical status (renal failure
and hypergammaglobulinemia) could be highly suggestive of
multiple myeloma, but the overlapping of a cutaneous rash and
eyelid swelling led the physicians to consider an allergic or
autoimmune disease. After a few days, deep neurological impair-
ment was prevalent, mimicking a brain hemorrhage that was
then excluded by CT scan and MRI. According to the changes
of the clinical status, several diagnoses were considered but not
supported by biochemical and serological tests and imaging,
until death finally supervened.
In conclusion, IPL with polyclonal hypergammaglobulinemia
is a rare entity that should be included in the differential diagno-
sis of several, more common pathologies (9). Nevertheless, this
report stresses that all the findings from the clinical history
examination, together with autopsy, must be interpreted with
considerable caution. The forensic pathologist, as well as the
hospital medical staff, must have an in-depth knowledge and a
practical experience of such cases to avoid misinterpretations
that could, in the worst cases, lead to a miscarriage of justice.
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